Ruixiang Xie

In Vitro Characterization for Human Serum Albumin Binding Sorafenib, A Multi Kinase Inhibitor: Spectroscopic Study

L. Qi, Zhong Lu, Gui-xin Li, 2014, Journal of Solution Chemistry.

TRPV3 inhibits colorectal cancer cell proliferation and migration by regulating the MAPK signaling pathway

Jingping Lin, Jieping Huang, Hui Yu, 2022, Journal of gastrointestinal oncology.

Cost-Utility Analysis of Camrelizumab Plus Chemotherapy Versus Chemotherapy Alone as a First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer in China

Qianchuan Zhao, Ting Chen, Hongfu Cai, 2022, Frontiers in Oncology.

Anti-PD-1/PD-L1 Antibody Therapy for Pretreated Advanced or Metastatic Nonsmall Cell Lung Carcinomas and the Correlation between PD-L1 Expression and Treatment Effectiveness: An Update Meta-Analysis of Randomized Clinical Trials

Qianchuan Zhao, X. You, X. Weng, 2018, BioMed research international.

Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial

Qianchuan Zhao, Lin Yang, Ruixiang Xie, 2023, Cost Effectiveness and Resource Allocation.